FDA.reportPublic FDA data

14 ML atezolizumab 60 MG/ML Injection

RxCUI
2119695
RxNorm name
14 ML atezolizumab 60 MG/ML Injection
Display name
14 ML atezolizumab 60 MG/ML Injection
Full name
14 ML atezolizumab 60 MG/ML Injection
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:39:03

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761034Tecentriqatezolizumab351(a)Rx2026-07-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
TECENTRIQATEZOLIZUMABGenentech, Inc.6fa682c9-a312-4932-9831-f286908660ee2026-05-20Warnings, Adverse reactionsExact identifier
rxcui: 2119695

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
6fa682c9-a312-4932-9831-f286908660eeatezolizumab 840 MG in 14 ML Injection [PSN] · 14 ML atezolizumab 60 MG/ML Injection [SCD] · atezolizumab 840 MG per 14 ML Injection [SY]345These highlights do not include all the information needed to use TECENTRIQ safely and effectively. See full prescribing information for TECENTRIQ. TECENTRIQ ® (atezolizumab) injection, for intravenous use Initial U.S. Approval: 201620260520